Cabiralizumab

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Cabiralizumab, covering 2021-08-31 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer [Phase 2]